369 filings
Page 3 of 19
8-K
r7c8q65jpjscz5o9w8q
16 Aug 21
Cellectar Announces Manufacturing and Supply Agreement with Evergreen Theragnostics for CLR-131, now known as iopofosine I-131
4:04pm
8-K
itv4ht4jom3pq7djw6b3
9 Aug 21
Cellectar Reports Financial Results for the Second Quarter 2021
8:40am
8-K
nd9gij2l7 emftdfy
13 Jul 21
Regulation FD Disclosure
4:05pm
8-K
fe0 kc51y
12 Jul 21
Cellectar Announces a Co-Development and Commercialization Collaboration with Development of Multiple Novel PDCs
4:08pm
8-K
azg3nvoot6 9knoh35
8 Jul 21
Cellectar to Participate in the Ladenburg Thalmann 2021 Virtual Healthcare Conference
4:25pm
8-K
5yysrq7o9h10fcmt0ag6
24 Jun 21
Cellectar Announces the Election of Dr. Asher Alban Chanan-Khan
8:40am
8-K
n5ja41
4 Jun 21
Cellectar Presents Data in Waldenstrom’s Macroglobulinemia in Poster at Mean treatment free remission 1.1 years and remains ongoing
9:06am
8-K
cxh1ysp3cy
20 May 21
Regulation FD Disclosure
4:03pm
8-K
50qld94x1qx856c03
14 May 21
Regulation FD Disclosure
4:05pm
8-K
em1n5d7cyklbby0ad
10 May 21
Cellectar Reports Financial Results for the First Quarter 2021
8:40am
8-K
2hz8s gps
3 May 21
Departure of Directors or Certain Officers
5:22pm
8-K
uyh5x4b38q
27 Apr 21
Cellectar Strengthens Global IP Position with Phospholipid Drug Conjugate Composition of Matter Patent in Eurasia, Australia, and Mexico
4:08pm
8-K
t5qf6rinzsyu
11 Mar 21
Cellectar to Participate at Upcoming Institutional Investor Conferences
4:05pm
8-K
cx5dfuesn9d s69sz
9 Mar 21
Cellectar Granted Japanese Composition of Matter Patent
4:05pm
8-K
wbvatqv
5 Mar 21
Cellectar to Participate at Upcoming Institutional Investor Conferences
4:05pm
8-K
dpcsmt6
2 Mar 21
Results of Operations and Financial Condition
4:07pm
8-K
gajcsyztxwf
25 Feb 21
Amendments to Articles of Incorporation or Bylaws
4:10pm
8-K
uu48h5zoajr 9qdl
10 Feb 21
Cellectar to Present at BIO CEO & Investor Digital Conference
4:07pm
8-K
vsc0wpurkq8askd6o
27 Jan 21
Cellectar Receives Orphan Drug Designation from the European Commission for CLR 131 in Waldenstrom’s Macroglobulinemia
4:05pm
8-K
i0kae73b0e p1a5
12 Jan 21
Regulation FD Disclosure
4:46pm